Zoledronic acid (ZA) infusion for osteoporosis is frequently associated with the onset of an acute phase reaction (APR) secondary to the activation of γδ T cell receptor (TCR) lymphocytes (γδ T cells) and to low vitamin D levels, similar to what is observed in chronic inflammation and autoimmunity. In this study we investigated whether the phenotype of γδ T cells is associated with APR and 25-OH vitamin D (25-OHvD) levels. For flow-cytometry analysis, peripheral blood samples were obtained from 52 osteoporotic women prior to 5-mg ZA intravenous infusion and from nine women (five with APR) one week later. Twenty-six/52 (50%) patients reported APR and APR+ cases had a higher percentage of central memory Th1-like γδ T cells. One week after ZA infusion, APR was associated with a decreased percentage of central memory Th1-like γδ T cells, an increase in the percentage and activation of effector memory Th1-like γδ T cells, and an increase in Th17-like γδ T cells. Lower 25-OHvD levels were significantly associated with APR, but no correlation was found between 25-OHvD level and γδ T cell percentage or subsets. In conclusion, patients experiencing APR related to ZA infusion have lower 25-OHvD levels and we suggest that the higher percentage of central memory Th1-like γδ T cells and the expansion of effector memory Th1-like and Th17-like γδ T cells are associated with the occurrence of APR.
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction / M. De Santis, F. Cavaciocchi, A. Ceribelli, C. Crotti, E. Generali, G. Fabbriciani, C. Selmi, M. Massarotti. - In: LUPUS. - ISSN 0961-2033. - 24:4-5(2015 Apr), pp. 442-447.
|Titolo:||Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction|
DE SANTIS, MARIA (Primo)
CAVACIOCCHI, FRANCESCA (Secondo)
SELMI, CARLO FRANCESCO (Corresponding)
|Parole Chiave:||adverse event; bisphosphonate; bone loss; Osteoporosis; zoledronate; Acute-Phase Reaction; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Osteoporosis; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Th1 Cells; Vitamin D; Autoimmunity; Rheumatology|
|Settore Scientifico Disciplinare:||Settore MED/16 - Reumatologia|
Settore MED/09 - Medicina Interna
|Data di pubblicazione:||apr-2015|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1177/0961203314559633|
|Appare nelle tipologie:||01 - Articolo su periodico|